TY - JOUR
T1 - Differences in performance on English and Hebrew versions of the MoCA in Parkinson's patients
AU - Xu, Yaqian
AU - Mirelman, Anat
AU - Saunders-Pullman, Rachel
AU - Mejia-Santana, Helen
AU - Caccappolo, Elise
AU - Raymond, Deborah
AU - Giladi, Nir
AU - Bressman, Susan
AU - Marder, Karen
AU - Alcalay, Roy N.
N1 - Publisher Copyright:
© 2020 The Authors
PY - 2020
Y1 - 2020
N2 - Introduction: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. Methods: The MoCA was analyzed in 483 Ashkenazi Jewish PD patients in Tel-Aviv and New York who had MoCA ≥21. Each section of the MoCA was compared between English and Hebrew. Linear regression models were used to test the association between MoCA performance and language. Results: Total MoCA scores were lower in Hebrew than in English (25.4 versus 26.1; P = 0.007), even after adjustment for age, sex, PD duration, genotype, levodopa equivalent dose, the Unified Parkinson's Disease Rating Scale (UPDRS-III), and Geriatric Depression Scale score in a linear model (P < 0.001). However, when language sections were removed from the total, scores were similar between the languages (Hebrew 23.7 versus English 23.4, P = 0.111). Conclusion: The language section of the MoCA may be more difficult in Hebrew. The comparability of MoCA in different languages requires further evaluation.
AB - Introduction: The Montreal Cognitive Assessment (MoCA), an instrument widely used for cognitive screening in Parkinson's disease (PD), is validated in Hebrew and English. However, it remains unknown whether the scores are comparable. Methods: The MoCA was analyzed in 483 Ashkenazi Jewish PD patients in Tel-Aviv and New York who had MoCA ≥21. Each section of the MoCA was compared between English and Hebrew. Linear regression models were used to test the association between MoCA performance and language. Results: Total MoCA scores were lower in Hebrew than in English (25.4 versus 26.1; P = 0.007), even after adjustment for age, sex, PD duration, genotype, levodopa equivalent dose, the Unified Parkinson's Disease Rating Scale (UPDRS-III), and Geriatric Depression Scale score in a linear model (P < 0.001). However, when language sections were removed from the total, scores were similar between the languages (Hebrew 23.7 versus English 23.4, P = 0.111). Conclusion: The language section of the MoCA may be more difficult in Hebrew. The comparability of MoCA in different languages requires further evaluation.
KW - LRRK2
KW - Language
KW - Parkinson's disease
KW - The Montreal Cognitive Assessment
UR - http://www.scopus.com/inward/record.url?scp=85088854348&partnerID=8YFLogxK
U2 - 10.1016/j.prdoa.2020.100042
DO - 10.1016/j.prdoa.2020.100042
M3 - Article
AN - SCOPUS:85088854348
SN - 2590-1125
VL - 3
JO - Clinical Parkinsonism and Related Disorders
JF - Clinical Parkinsonism and Related Disorders
M1 - 100042
ER -